← Back to Search

Urban Trail Expansion for Cardiovascular Disease

N/A
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* The entire population of Winnipeg
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 years
Awards & highlights
No Placebo-Only Group

Summary

Associations between the built environment and health behaviours are robust, however (1) it remains unclear if the behaviours they elicit lead to meaningful improvements in health outcomes, at the population level and (2) little experimental evidence exists supporting these associations. The primary objective of this study is to capitalize on an urban natural experiment to determine if changing the built environment to support physical activity will (1) reduce the burden of CVD within a population and (2) if it's a cost-effective population intervention. An interrupted time series analysis will be performed over a period of 19 years to determine if the expansion of an urban trail network is associated with reductions in major advserse cardiovascular events (MACE) and CVD-related risk factors within a large urban centre in Canada.

Eligible Conditions
  • Cardiovascular Disease
  • Cardiovascular Risk
  • Diabetes

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Major adverse cardiovascular events
Secondary study objectives
Cardiovascular disease-related risk factors
Other study objectives
Trail counts

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Urban Trail ExpansionExperimental Treatment1 Intervention
Neighbourhoods within 400m to 800m of a neely built greenway, defined as a multi-use concrete/asphalt trail that was \>4km in length)
Group II: ControlActive Control1 Intervention
Neighbourhoods that are located beyond 400 to 800m of a newly built greenway

Find a Location

Who is running the clinical trial?

University of TorontoOTHER
715 Previous Clinical Trials
1,022,693 Total Patients Enrolled
Unity Health TorontoOTHER
556 Previous Clinical Trials
454,181 Total Patients Enrolled
Ontario Agency for Health Protection and PromotionOTHER_GOV
9 Previous Clinical Trials
22,968 Total Patients Enrolled
~29 spots leftby Nov 2025